凱升(00102.HK)停牌 台灣投資夥伴逾1億美元售俄渡假村
凱升(00102.HK)昨日(11日)停牌,待公布內幕消息。根據台灣證交所上市的伍豐科技披露及相關報道,伍豐子公司持有20%權益的Oriental Regent Ltd(東雋),以1.16億美元將持有的俄羅斯賭場及渡假村發展項目的營運公司G1娛樂全部股權,轉讓予俄羅斯當地公司Dalnevostochniy Aktiv LLC。
根據凱升的年報,該集團持有東雋77.5%股權,並藉此間接經G1娛樂,參與俄羅斯上晶虎綜合渡假村投資。伍豐科技料完成交易後,東雋將向其返還2,800萬美元投資,並將其涉足俄羅斯的風險減至零,但是料錄得虧損1,839萬美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.